Physiological and clinical effects of diurnal noninvasive ventilation in hypercapnic COPD

European Respiratory Journal

Volumn 26, Issue 6, 2005, Pages 1016-1023

  Diaz O ^a   Begin P ^b   Andresen, M ^a   Prieto, M E ^a   Castillo, C ^a   Jorquera, J ^a   Lisboa, C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Dyspnoea; Exercise capacity; Hypercapnia; Noninvasive ventilation

Indexed keywords

SALBUTAMOL;

ADULT; AGED; AIRWAY RESISTANCE; ANALOG DIGITAL CONVERTER; ANALYZER; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BREATHING PATTERN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DISEASE ACTIVITY; DYSPNEA; EXERCISE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; HYPERCAPNIA; INHALATION; MAJOR CLINICAL STUDY; MALE; MOUTH OCCLUSION PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT PARAMETERS; SPIROMETER; SPIROMETRY; TIDAL VOLUME; VENTILATOR; WALKING;

AGED; ANALYSIS OF VARIANCE; BLOOD GAS ANALYSIS; CARBON DIOXIDE; CHI-SQUARE DISTRIBUTION; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCAPNIA; MALE; MIDDLE AGED; PROBABILITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RESPIRATORY FUNCTION TESTS; RESPIRATORY MECHANICS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SPIROMETRY; TREATMENT OUTCOME;

EID: 29244465545     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00033905     Document Type: Article

References (37)

1. Brochard L, Mancebo J, Elliott MW. Noninvasive ventilation for acute respiratory failure. Eur Respir J 2002; 19: 712-721.
2. Elliot MW. Noninvasive ventilation in chronic ventilatory failure due to chronic obstructive pulmonary disease. Eur Respir J 2002; 20: 511-514.
3. Díaz O, Bégin P, Torrealba B, Jover E, Lisboa C. Effects of nonivasive ventilation on lung hyperinflation in stable hypercapnic COPD. Eur Respir J 2002; 20: 1490-1498.
4. Elliott MW, Mulvey DA, Moxham J, Green M, Branthwaite MA. Domiciliary nocturnal nasal intermittent positive pressure ventilation in COPD: mechanisms underlying changes in arterial blood gas tensions. Eur Respir J 1991; 4: 1044-1052.
5. Meecham Jones DJ, Paul EA, Jones PW, Wedzicha JA. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med 1995; 152: 538-544.
6. Celli BR, W, MacNee W, Agusti A, et al. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Resp J 2004; 23: 932-946.
7. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
8. Knudson RJ, Lebowist MD, Holberg CI, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and age. Am Rev Respir Dis 1983; 127: 725-734.
9. Whitelaw WA, Derenne JP, Milic-Emili J. Occlusion pressure as a measure of respiratory center output in conscious man. Respir Physiol 1975; 23: 181-199.
10. Hussain S, Pardy R, Dempsey J. Mechanical impedance as determinant of inspiratory neural drive during exercise in humans. J Appl Physiol 1985; 59: 365-375.
11. Ramonatxo M, Boulard P, Prefaut C. Validation of a noninvasive tension-time index of inspiratory muscles. J Appl Physiol 1995; 78: 646-653.
12. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-758,
13. Witek TJ, Mahler DA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J 2003; 21: 267-272.
14. Reardon J, Awad E, Normandin E, Vale F, Clark B, ZuWallak RL. The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea. Chest 1994; 105: 1046-1052.
15. Butland RJA, Pang J, Gross ER, Woodcock AA, Geddes DM. Two, six and twelve-minute walking tests in respiratory diseases. BMJ 1982; 284: 1607-1608.
16. Borg GAV. Psychophysical basis of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-381.
17. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155: 1278-1282.
18. Vickers Aj, Altman DG. Analysing controlled trials with baseline and follow up measurements. BMJ 2001; 323: 1123-1124.
19. Ambrosino N, Montagna T, Nava S, et al. Short term effect of intermittent negative pressure ventilation in COPD patients with respiratory failure. Eur Respir J 1990; 3: 502-508.
20. Scano G, Gigliotti F, Duranti R, Spinelli A, Gorini M, Schiavina M. Changes in ventilatory muscle function with negative pressure ventilation in patients with severe COPD. Chest 1990; 97: 322-327.
21. Gigliotti F, Spinelli A, Duranti R, Gorini M, Goti P, Scano G. Four-week negative pressure ventilation improves respiratory function in severe hypercapnic COPD patients. Chest 1994; 105: 87-94.
22. Nava S, Fanfulla F, Frigerio P, Navalesi P. Physiologic evaluation of 4 weeks of nocturnal nasal positive pressure ventilation in stable hypercapnic patients with chronic obstructive pulmonary disease. Respiration 2001; 68: 573-583.
23. Bellemare F, Grassino A. Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. J Appl Physiol 1983; 55: 8-15.
24. O'Donnell DE, Voduc N, Fitzpatrick M, Webb KA. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 86-94.
25. O'Donnell DE, Flüge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832-840.
26. Gutiérrez M, Beroíza T, Contreras G, et al. Weekly cuirass ventilation improves blood gases and inspiratory muscle function in patients with chronic air-flow limitation and hypercarbia. Am Rev Respir Dis 1988; 138: 617-623.
27. Renston JP, DiMarco AF, Supinsky GS. Respiratory muscle rest using nasal BiPAP ventilation in patients with stable severe COPD. Chest 1994; 105: 1053-1060.
28. Strumpf DA, Millman RP, Carlisle CC, et al. Nocturnal positive-pressure ventilation via nasal mask in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 144: 1234-1238.
29. Gay PC, Hubmayr RD, Stroetz RW. Efficacy of nocturnal nasal ventilation in stable, severe chronic obstructive pulmonary disease during a 3-month controlled trial. Mayo Clin Proc 1996; 71: 533-42.
30. Casanova C, Celli B, Tost L, et al. Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest 2000; 118: 1582-90.
31. Clini E, Sturani C, Rossi A, et al. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20: 529-538.
32. Nava S, Ambrosino N, Rubini F, et al. Effect of nasal pressure support ventilation and external PEEP on diaphragmatic activity in patients with severe stable COPD. Chest 1993; 103: 143-150.
33. Criner GJ, Brennan K, Travaline JM, Kreimer D. Efficacy and compliance with noninvasive positive pressure ventilation in patients with chronic respiratory failure. Chest 1999; 116: 667-675.
34. Wijkstra PJ, Lacasse Y, Guyatt GH, et al. A meta-analysis of nocturnal noninvasive positive pressure ventilation in patients with stable COPD. Chest 2003; 124: 337-343.
35. Elliot MW, Simonds AK, Carroll MP, Wedzicha JA, Branthwaite MA. Domiciliary nocturnal nasal intermittent positive pressure ventilation in hypercapnic respiratory failure due to chronic obstructive lung disease: effects on sleep and quality of life. Thorax 1992; 47: 342-348.
36. Schonhofer B, Geibel M, Sonneborn M, Haidl P, Kohler D. Daytime mechanical ventilation in chronic respiratory insufficiency. Eur Respir J 1997; 10: 2840-46.
37. Fernandez E, Weiner P, Meltzer E, Lutz MM, Badish DB, Cherniack RM. Sustained improvement in gas exchange after negative pressure ventilation for 8 hours per day on 2 successive days in chronic airflow limitation. Am Rev Respir Dis 1991; 144: 390-394.